Z51.12
BillableEncounter for antineoplastic immunotherapy
Z51.12 is the ICD-10-CM code for Encounter for antineoplastic immunotherapy. It is a billable, specific code valid for reimbursement.
Z00-Z99 Factors influencing health status and contact with health services
What this means — in plain language
MedlinePlus · NIHWhat is immunotherapy? Immunotherapy is a cancer treatment that helps your immune system fight cancer. It is a type of biological therapy. Biological therapy uses substances made from living organisms or versions of these substances made in a lab. Immunotherapy isn't used for all cancers, and the response to treatment varies. If you're getting immunotherapy, your health care provider will monitor your treatment…
Read more about Cancer Immunotherapy at MedlinePlus ↗Source: U.S. National Library of Medicine (MedlinePlus). Informational only — not medical advice.
Medications indicated for this condition
FDA labeling- Promethazine›
- AcetazolamideCarbonic Anhydrase Inhibitor [EPC]›
- Neostigmine›
- Palonosetron›
- Promethazine Hci›
- Sugammadex›
Drugs whose FDA labeling lists this condition's category among its indications. Informational only — not a treatment recommendation or medical advice.
Conditions mapped to this code
MedlinePlus · NIHPlain-language health-topic references grounded in MedlinePlus (NIH/NLM).
Frequently asked questions
Source: CMS ICD-10-CM FY2026. For informational purposes only — not medical advice. See our medical disclaimer.
Look up another ICD-10 code or condition